Skip to main content
NCBI home page
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2026 Mar 4;17:1777773. doi: 10.3389/fimmu.2026.1777773

Alleviation of tissue adhesion using dual-functional methacrylated gelatin via immunomodulation and antifibrotic activity

Pei Yuan 1, Shichun Feng 1, Chong Tang 1, Xuesong Gao 1, Shengkui Qiu 1, Geshuyi Chen 2,*
PMCID: PMC12995757  PMID: 41859078

Abstract

Intestinal adhesion is one of the most prevalent clinical conditions, affecting millions of patients globally. However, effective strategies to decrease the incidence of intestinal adhesion remain insufficient. In this study, we developed a novel and unreported dual-functional methacrylated gelatin (nhGelMA) that can regulate inflammation and antifibrotic functions by integrating gelatin methacryloyl (GelMA), Houttuynia cordata extract, and nintedanib. First, optimal concentrations of GelMA hydrogels were prepared and screened, followed by the selection of appropriate concentrations of Houttuynia cordata extract and nintedanib to prepare the final nhGelMA. Subsequently, nhGelMA was characterized, and its biocompatibility and biological functions were analyzed. The results indicated that nhGelMA exhibited good biocompatibility, no organ toxicity, and the ability to modulate the expression level of inflammation and fibronectin (FN). Finally, nhGelMA hydrogel was applied in the preventive treatment of hemorrhagic intestinal adhesion, and the results indicated that nhGelMA effectively reduced the deposition of FN, laminin (LAMA), and collagen type I (Col1), as well as decreased the infiltration of macrophages and neutrophils, thereby preventing the occurrence of intestinal adhesion. Importantly, the further transcriptomics demonstrated that nhGelMA could regulate protein digestion, absorption, and adhesion, as well as reconstruct the anatomical structure, contributing to the alleviation of hemorrhagic intestinal adhesion.

Keywords: biomaterials, houttuynia cordata extract, hydrogel, intestinal adhesion, nintedanib, tissue engineering

1. Introduction

Intestinal adhesion is a prevalent clinical condition, which affects millions of patients globally (1–5). In general, the incidence rate of intestinal adhesion exceeds 50% after injuries or surgeries involving the abdominal cavity (2, 4, 6). Patients with intestinal adhesion experience intermittent abdominal colic, which can progress to mechanical intestinal obstruction, necessitating surgical intervention during episodes of intestinal dysfunction (7–9). Therefore, preventing the occurrence of intestinal adhesion is critical for reducing postoperative adverse symptoms and enhancing the quality of life of patients (2, 4, 8, 10, 11). However, effective strategies to decrease the incidence of intestinal adhesion remain insufficient.

Tissue engineering and biomaterials present promising approaches for mitigating intestinal adhesion (12–16). Based on previous studies, abnormal tissue healing caused by bleeding and inflammation in the abdominal cavity primarily contributes to intestinal adhesion (17). Furthermore, the secretion and deposition of fibronectin serve as key linkers in intestinal adhesion (17). Therefore, regulating the secretion and deposition of fibronectin is crucial for preventing the occurrence of intestinal adhesion. Meanwhile, fibronectin is primarily synthesized and secreted by fibroblasts and macrophages (18). Thus, a dual-dimensional approach that targets the cellular level (by reducing the infiltration of inflammatory cells and fibroblasts) and the molecular level (by decreasing the synthesis and secretion of fibronectin) is a promising and effective strategy to alleviate intestinal adhesion.

Houttuynia cordata extract, a traditional herbal component, exhibits excellent biocompatibility, anti-inflammatory, low cost, and high potential for clinical translation properties (19, 20). Nintedanib, which is an antifibrotic agent with hypotoxicity, could effectively inhibit the generation and deposition of fibronectin (21, 22). Therefore, integrating Houttuynia cordata extract with nintedanib can alleviate the factors influencing intestinal adhesion at cellular and molecular levels. Furthermore, the early phase of acute inflammation and hemorrhagic exudation is a critical period that promotes the accumulation of factors contributing to intestinal adhesion, during which the continuous regulation of local inflammatory factors influencing intestinal adhesion is necessary (23). However, the combination of Houttuynia cordata extract and nintedanib alone may not suffice the demand for continuous treatment. GelMA, which is a popular hydrogel, has good biocompatibility and plasticity, making it suitable for applications in tissue regeneration and repair (24, 25). Its loosely crosslinked network enables sustained drug release, thereby addressing the need for continuous and stable drug delivery (25, 26). Moreover, the integration of GelMA, Houttuynia cordata extract, and nintedanib to alleviate hemorrhagic intestinal adhesion has not been reported to date.

Thus, in this study, GelMA, Houttuynia cordata extract, and nintedanib were integrated to develop a dual-functional methacrylated gelatin (nhGelMA) that can regulate inflammation and antifibrotic functions (Figures 1A–C). First, optimal concentrations of GelMA hydrogels were prepared and screened, followed by the selection of appropriate concentrations of Houttuynia cordata extract and nintedanib to prepare the final nhGelMA. Subsequently, nhGelMA was characterized, and its biocompatibility and biological functions were analyzed. The results indicated that nhGelMA exhibited good biocompatibility, no organ toxicity, and the ability to modulate the expression level of inflammation and fibronectin (FN). Finally, nhGelMA hydrogel was applied in the preventive treatment of hemorrhagic intestinal adhesion, and the results indicated that nhGelMA effectively reduced the deposition of FN, laminin (LAMA), and collagen type I (Col1), as well as decreased the infiltration of macrophages and neutrophils, thereby preventing the occurrence of intestinal adhesion. Importantly, the further transcriptomics demonstrated that nhGelMA could regulate protein digestion, absorption, and adhesion, as well as reconstruct the anatomical structure, contributing to the alleviation of hemorrhagic intestinal adhesion.

Figure 1.

Figure composed of three panels illustrating hydrogel preparation and its effects. Panel A details chemical synthesis of GelMA from gelatin, then shows formulation of nhGelMA by adding Nintedanib and Houttuynia cordata. Panel B depicts loading BV2 cells or fibrocytes into nhGelMA, forming BnhGelMA or FnhGelMA, with gene expression outcomes for TNFα, IL6, IL1, and FN shown graphically. Panel C provides cross-sectional illustrations of intestine: the original tissue, a disease model with inflammation, and comparison of untreated versus treated with hydrogel, showing reduced inflammatory cells and restored extracellular matrix components, with a labeled legend of key cell types and proteins.

Open in a new tab

Schematic illustration of alleviation hemorrhagic intestinal adhesion using dal-functional methacrylated gelatin (nhGelMA) via immunomodulation and anti-fibrosis. (A) The preparation process of nhGelMA is detailed. (B) The evaluation of nhGelMA functions pertaining to immunomodulation and anti-fibrosis in vitro. (C) The application of nhGelMA in vivo demonstrates its efficacy in alleviating hemorrhagic intestinal adhesion.

2. Results and discussion

2.1. Preparation of nhGelMA

Previous studies have indicated that abnormal tissue repair resulting from injury, bleeding, and inflammatory infections is the primary factor contributing to intestinal adhesion (12–14). Furthermore, the secretion and deposition of fibronectin serve as critical linkers in the formation of intestinal adhesion, which are primarily synthesized and secreted by fibroblasts and macrophages (18). Therefore, using a dual-dimensional approach aimed at reducing the infiltration of inflammatory cells and fibroblasts, as well as the synthesis and secretion of fibronectin, has great application potential in developing an effective repair strategy to alleviate intestinal adhesion. The development of hydrogels and drugs provides the technical support necessary to meet the aforementioned requirements for mitigating intestinal adhesion.

Gelatin, which is a natural material, has been widely applied in daily life and clinic because of its excellent biocompatibility and biosafety. The exposed amino (–NH2) and hydroxyl (–OH) groups on the amino acid chains of gelatin provide outstanding plasticity and serve as a chemical basis for the modification required to prepare methacryloylated gelatin (GelMA) (27, 28). The carbon–carbon double bonds of GelMA could be activated under the simultaneous excitation of the photoinitiator (LAP) and ultraviolet light, forming new links that lead to a network structure, which macroscopically manifests as a hydrogel (Figure 2A). The convenience of the gelation of GelMA hydrogels, along with the crosslinked network formed after gelation, provides an operational and structural basis for drug loading and release, making it an excellent drug carrier. In this study, GelMA was synthesized, and nuclear magnetic resonance hydrogen spectroscopy (NHR-H) was performed on the gelatin and GelMA groups to confirm chemical grafting. The results indicated that the GelMA group exhibited double peaks corresponding to successful grafting between 5 and 6 ppm (Figure 2B). Furthermore, the gross views of GelMA preparation and hydrogel formation are presented in Figure 2C to confirm the successful preparation of the hydrogel. The results indicated that GelMA was successfully synthesized, and hydrogels were formed. The concentration of the hydrogel remarkably influences the density of the crosslinked network within the scaffold, thereby affecting its mechanical strength and nutrient permeability. At a hydrogel concentration of 1%, the internal crosslinked network fails to form sufficient mechanical strength to maintain its macroscopic bulk morphology, thereby resulting in a fluid state that is unsuitable for subsequent drug loading. As the concentration increases, the mechanical strength of the hydrogel escalates (Figure 2D). However, enhancing strength to encapsulate cells leads to a reduction in cell viability with increasing concentration (Figure 2E). Therefore, considering the operational feasibility and the impact on cellular viability, 5% GelMA concentration was used for the subsequent experiments. In this study, Houttuynia cordata extract, which is a traditional natural herbal component, showed excellent biocompatibility and anti-inflammatory functions, which were used to modulate inflammatory cells following intestinal injury. However, the optimal dosage remains to be confirmed. Consequently, GelMA was prepared using varying concentrations of Houttuynia cordata extract (hGelMA) to assess its toxicity on fibroblasts. The results indicated that Houttuynia cordata extract is safe at concentrations below 10 mg/mL (Figure 2G). Therefore, 10 mg/mL Houttuynia cordata extract was selected for subsequent experiments. Similarly, nintedanib, which is a well-established antifibrotic drug, was utilized to diminish FN production in this study. The cytotoxicity tests conducted at various concentrations revealed that nintedanib is safe at concentrations below 20 µg/mL (Figure 2F). Thus, 20 µg/mL nintedanib was established for subsequent experiments. Finally, nhGelMA hydrogel was successfully prepared by mixing 20 µg/mL nintedanib and 10 mg/mL Houttuynia cordata extract into 5% GelMA (Figure 3A).

Figure 2.

Figure containing multiple panels illustrating the synthesis and analysis of GelMA hydrogel. Panel A shows a schematic of gelatin modification to GelMA, leading to hydrogel formation via UV photocrosslinking. Panel B provides side-by-side NMR spectra comparing gelatin and GelMA. Panel C displays photographs and steps of GelMA synthesis and hydrogel formation, including images of powdered gelatin, GelMA, and their solutions with reaction steps annotated. Panels D to G present bar graphs; D shows compressive modulus for varying GelMA concentrations, E shows CCK8 values for different concentrations, while F and G show CCK8 assay results of cells treated with Nintedanib and Houttuynia cordata, respectively, with significant differences indicated by asterisks.

Open in a new tab

Preparation of nhGelMA. (A) A schematic illustration of the synthesis process for nhGelMA. (B) The NMR-H spectra of gelatin and GelMA. (C) Gross views of the synthesized nhGelMA. (D) The compressive modulus of 1%, 5%, 10%, and 15% GelMA. (E) The CCK8 test results for the Blank, 1% GelMA, 5% GelMA, 10% GelMA, and 15% GelMA groups. (F) CCK8 test results for nGelMA with 0, 1, 10, 20, and 50 µg/ml of nintedanib. (G) CCK8 of hGelMA with 0, 1, 10, 100, 1000,10000, and 100000 ug/ml of houttuynia cordata extract. *P < 0.05. ns P > 0.05.

Figure 3.

Panel A shows a schematic of GelMA combining with nintedanib and Houttuynia cordata to form nhGelMA. Panel B displays photos of clear and brown solutions in vials under “Sol,” “UV,” and “Gel” conditions for three samples: GelMA, nGelMA, and nhGelMA. Panels C through H present charts and graphs analyzing modulus, viscosity, swelling, remaining mass ratio, cumulative release of drugs, and compressive modulus for the three hydrogel variants, showing similar trends and statistical comparison.

Open in a new tab

Characterizations of the hydrogels. (A) The schematic illustration of nhGelMA preparation. (B) The gross views of GelMA, nGelMA, and nhGelMA hydrogels before and after UV-irradiation. (C–F) Rheological analyses (C), viscosity (D), swelling ratio (E), and degradation (F) in GelMA, nGelMA, and nhGelMA groups. (G) The cumulative release of nintedanib and houttuynia cordata extract. (H) The compressive modulus for GelMA, nGelMA, and nhGelMA hyrdogels. ns P > 0.05.

2.2. Characterizations of the hydrogels

Further verification of the influence of the incorporated Houttuynia cordata extract and nintedanib on hydrogel characterization is necessary to evaluate their safety and feasibility. The gross views of the transition from sol to gel for GelMA, hGelMA, and nhGelMA, along with rheological and viscosity assessments, indicated that the incorporation of Houttuynia cordata extract and nintedanib does not affect the rheological properties (Figures 3B–D). The results of swelling tests indicated that the swelling ratio of the hydrogels is below 150%, which is considered as a safe range for swelling in the peritoneal cavity (Figure 3E). Furthermore, degradation experiments revealed that GelMA, hGelMA, and nhGelMA exhibited similar degradation rates, degrading over 50% within 2 days, thereby confirming their biodegradability and safety (Figure 3F). The sustained release of Houttuynia cordata extract and nintedanib in nhGelMA is an important characteristic for the current repair strategy. The in vitro sustained release results confirmed that Houttuynia cordata extract and nintedanib could release over 60% of the drug within 3 days (Figure 3G), indicating the application potential of nhGelMA in achieving a time-matched release to regulate inflammatory cells and reduce fibronectin generation after intestinal damage. Moreover, the compressive modulus of GelMA, hGelMA, and nhGelMA indicated that the addition of Houttuynia cordata extract and nintedanib does not affect the mechanical properties (Figure 3H). In addition, SEM analysis showed that the hydrogels possessed similar porous network structures (Figures 4A–C). Elemental analysis revealed that the incorporation of Houttuynia cordata extract and nintedanib increased the ratio of carbon (C) and oxygen (O) (Figures 4A–D). Furthermore, the results of XRD and FTIR indicated similar crystalline structures and chemical bonds in GelMA, hGelMA, and nhGelMA hydrogels (Figures 4E, F).

Figure 4.

Composite figure displays SEM micrographs at 500X, 200X, and 100X, elemental mapping for C, N, O, and EDS spectra for GeIMA, nGeIMA, and nhGeIMA hydrogels in panels A, B, and C, respectively. Panel D presents a bar chart of cps/eV for elements in the three hydrogel types. Panel E shows X-ray diffraction patterns with GelMA, nGelMA, and nhGelMA plotted in blue, red, and green. Panel F provides FTIR spectra comparing the three materials by wavenumber.

Open in a new tab

The structure and element of the hydrogels. (A-C) The SEM and elemental distribution images in GelMA, nGelMA, and nhGelMA groups. (D) The quantitative analysis of carbon, nitrogen, and oxygen. (E, F) The XRD and FTIR of GelMA, nGelMA, and nhGelMA.

2.3. Biocompatibility of the hydrogels

The biocompatibility of nhGelMA is crucial for its potential in vivo applications, which needs further clarification. In this study, fibroblasts (the primary cells responsible for FN production) and macrophages (the main cells that secrete inflammatory factors) were selected as validating seed cells to evaluate its biocompatibility (Figure 5A). The results of live/dead staining indicated that fibroblasts and macrophages survived well in GelMA, hGelMA, and nhGelMA with only a few dead cells (Figures 5B–G). In addition, assessing whether the application of the hydrogel in vivo causes organ toxicity is important. The results of H&E staining indicated that the application of nhGelMA in vivo did not lead to significant changes in the heart, liver, spleen, lungs, or kidneys compared with an untreated control group, thereby confirming the absence of organ toxicity (Figure 5H). Finally, gene expression analyses related to FN and inflammatory factors were conducted in the GelMA and nhGelMA groups to further investigate the functions of Houttuynia cordata extract and nintedanib in nhGelMA in vitro. The results indicated that nhGelMA could reduce the expression level of the FN gene in fibroblasts, as well as the expression level of the inflammatory genes TNFα, IL6, and IL1 in macrophages (Figures 5I–L), implying the excellent anti-inflammatory properties of nhGelMA and Houttuynia cordata extract. Therefore, nhGelMA has predefined antifibrotic and inflammatory regulatory functions, making it suitable for further in vivo experiments aimed at alleviating intestinal adhesion.

Figure 5.

Scientific figure with multiple panels. Panel A shows a workflow diagram for sequential BV2 and fibrocyte cell loading into hydrogels and subsequent gene expression analysis for TNFα, IL6, IL1, and FN. Panels B and C display live/dead fluorescence microscopy images of cells in GelMA, nhGelMA, and nGElMA hydrogels, with quantitative bar graphs (D–G) for live/dead cell ratios showing no significant differences. Panel H contains H&E-stained histology images of heart, liver, spleen, lung, and kidney from control and nhGelMA groups. Panels I–L present bar graphs comparing gene expression levels of FN, TNFα, IL6, and IL1 across different treatment groups, with significant differences indicated by asterisks.

Open in a new tab

Biocompatibility and organ toxicity. (A) The schematic illustration of evaluating nhGelMA functions pertaining to immunomodulation and anti-fibrosis in vitro. (B, C) The live/dead staining of fibrocytes and BV2 loaded GelMA, nGelMA, and nhGelMA hydrogels at 3 days. (D-G) The quantitative analysis of live/dead staining for fibrocytes and BV2. (H) Organ toxicity of nhGelMA. (I-L) The genes expressive level of FN (I), TNFα (J), IL6 (K), and IL1 (L). *P < 0.05. ns P > 0.05.

2.4. The application of nhGelMA in alleviating hemorrhagic intestinal adhesion

The ability of nhGelMA to effectively alleviate intestinal adhesion is the most important aspect in this study. The untreated intestinal injury served as the control group, whereas the experimental group received nhGelMA treatment (Figure 6B). The gross views made 3 days postsurgery indicated that the untreated group developed severe intestinal adhesion, whereas the nhGelMA group exhibited no adhesion (Figure 6C). Furthermore, PCR analysis was performed in the control and nhGelMA groups to further elucidate the mechanism by which nhGelMA alleviates adhesion. The results indicated that nhGelMA not only reduced the expression level of adhesion-related genes, namely, FN (Figure 6D), LAMA (Figure 6E), and Coll (Figure 6F), but also downregulated the expression level of inflammation-related genes, namely, CD3 (Figure 6G), CD68 (Figure 6H), TNFα (Figure 6I), IL6 (Figure 6J), and IL1 (Figure 6K). Further histological staining with H&E, Masson, FN, LAMA, and Col1 in the untreated and nhGelMA groups revealed the remarkable accumulation of adhesion-related proteins in the adherent intestinal wall of the untreated group (Figure 7). By contrast, only a small amount of these proteins was found in the treatment group, indicating that nhGelMA hydrogel plays a crucial role in reducing adhesion (Figures 7A–D). In addition, inflammation-related staining for CD68 and CD3 showed that the inflammatory infiltration in the untreated group was significantly higher than that in the control group (Figures 7A, E, F). Therefore, nhGelMA can alleviate intestinal adhesion by reducing adhesion and inflammation (Figure 6A).

Figure 6.

Panel A presents a schematic of tissue injury and treatment, differentiating between untreated and treated groups, with labeled cell types and extracellular matrix components. Panel B shows sequential photographs of a surgical procedure including preparation, tissue exposure, modeling, treatment, ultraviolet lighting, and closure with sutures. Panel C provides gross images comparing untreated and treated intestinal tissue following surgery. Panels D to K display bar graphs quantifying relative mRNA expression of fibronectin, laminin, collagen 1, CD3, CD68, TNFα, IL6, and IL1, showing reduced levels in the treated group compared to control, with statistical significance indicated.

Open in a new tab

The application of nhGelMA in alleviating hemorrhagic intestinal adhesion. (A) The schematic illustration of the process and mechnism in alleviating hemorrhagic intestinal adhesion. (B) The process of the surgery. (C) The gross views of the untreated and treated intestine. (D-K) The genes expressive level of FN (D), LAMA (E), Col1 (F), CD3 (G), CD68 (H), TNFα (I), IL6 (J), and IL1 (K). *P < 0.05.

Figure 7.

Figure contains histological and immunofluorescence images of intestinal tissue in control and nhGelMA groups, displaying H&E, Masson, FN/LAMA, Col1, CD3, and CD68 staining across interface, inner, and surface regions. Fluorescence intensity bar graphs compare marker expression, showing significant differences between groups and regions for FN, Laminin, Col1, CD3, and CD68 markers, with statistical significance indicated.

Open in a new tab

Histological staining of untreated and treated intestine. (A) The H&E, Masson, FN/LAMA/DAPI, Col1/DAPI, and CD68/CD3/DAPI staining in Ctrl and nhGelMA groups. (B-F) The quantitative analysis of fluorescence intensity in FN (B), LAMA (C), Col1 (D), CD3 (E) and CD68 (F). *P < 0.05. ns P > 0.05.

2.5. The mechanism analysis of nhGelMA in alleviating hemorrhagic intestinal adhesion

To further clarify the mechanism analysis of nhGelMA in alleviating hemorrhagic intestinal adhesion, transcriptomics was conducted on the nhGelMA and untreated (Ctrl) groups 3 days post-surgery. PCA and expression distribution analyses demonstrated good biological replicates within both the nhGelMA and Ctrl groups, suggesting the reliability of the experimental data (Figure 8A; Supplementary Figure S1A), which was further corroborated by correlation analysis (Figure 8C). The Venn diagram revealed that the nhGelMA group detected a total of 12,527 genes, of which 602 were unique. In contrast, the Ctrl group identified 12,386 genes, including 461 unique genes. Notably, both groups shared a total of 11,925 common genes (Supplementary Figure S2A). Differential statistics revealed that nhGelMA upregulated 914 genes and downregulated 952 genes, while 1866 genes exhibited no significant expression differences (Figure 8B). Heatmap and volcano plots of the differentially expressed genes indicated a number of significantly differentially expressed genes, suggesting that this strategy mitigates intestinal adhesion through various potential mechanisms (Figure 8D; Supplementary Figure S2B). Furthermore, GO functional annotation analysis showed that the differential genes were distributed across biological process, cellular component, and molecular function, indicating that the strategy for alleviating intestinal adhesion involves comprehensive regulation (Figure 8E). To elucidate the specific regulatory pathways associated with this strategy, KEGG and GO enrichment analyses were performed (Figures 8F, G). The results indicated that nhGelMA can regulate ECM-receptor interactions, as well as pathways Cytokine-cytokine receptor interaction, Cell adhesion molecules, Protein digestion and absorption, PPAR signaling pathway, cell adhesion, Cytokine-cytokine receptor interaction, and anatomical structure morphogenesis, to alleviate local adhesion while remodeling the local intestinal mucosal structure. Furthermore, the heatmap of Protein digestion and absorption, Cell adhesion molecules, PPAR signaling pathwayand Cytokine-cytokine receptor interaction (Supplementary Figures S3A-D) showed the upregulated and downregulated genes, which related to alleviation of hemorrhagic intestinal adhesion. Therefore, nhGelMA could regulate protein digestion, absorption, and adhesion, as well as reconstruct the anatomical structure, contributing to the alleviation of hemorrhagic intestinal adhesion.

Figure 8.

Multipanel scientific figure comparing Ctrl and nhGelMA groups in gene expression analysis using RNA-seq. Panel A shows a PCA plot separating sample groups. Panel B displays a bar graph with the numbers of upregulated, downregulated, and total differentially expressed genes. Panel C contains a correlation heatmap clustering the samples. Panel D features a gene expression heatmap with blue and red gradients. Panel E presents GO annotation bar graphs with enriched biological processes, cellular components, and molecular functions. Panel F is a KEGG enrichment dot plot highlighting key signaling and interaction pathways. Panel G is a GO enrichment dot plot emphasizing biological and cellular processes.

Open in a new tab

The mechanism analysis of nhGelMA in alleviating hemorrhagic intestinal adhesion. (A) PCA analysis of nhGelMA and Ctrl groups. (B) The differential expressive genes (DEGs) between nhGelMA and Ctrl groups. (C) Correlation analysis between nhGelMA and Ctrl groups. (D) Heatmap analysis in the two groups. (E) GO annotations analysis of DEGs in the two groups. (F, G) KEGG and GO enrichment analyses.

3. Conclusion

Intestinal adhesion is one of the most prevalent clinical conditions, affecting millions of patients globally. However, effective strategies to decrease the incidence of intestinal adhesion remain insufficient. in this study, GelMA, Houttuynia cordata extract, and nintedanib were integrated to develop a dual-functional methacrylated gelatin (nhGelMA) that can regulate inflammation and antifibrotic functions. First, optimal concentrations of GelMA hydrogels were prepared and screened, followed by the selection of appropriate concentrations of Houttuynia cordata extract and nintedanib to prepare the final nhGelMA. Subsequently, nhGelMA was characterized, and its biocompatibility and biological functions were analyzed. The results indicated that nhGelMA exhibited good biocompatibility, no organ toxicity, and the ability to modulate the expression level of inflammation and FN. Finally, nhGelMA hydrogel was applied in the preventive treatment of hemorrhagic intestinal adhesion, and the results indicated that nhGelMA effectively reduced the deposition of FN, LAMA, and Col1, as well as decreased the infiltration of macrophages and neutrophils, thereby preventing the occurrence of intestinal adhesion. Importantly, the further transcriptomics demonstrated that nhGelMA could regulate protein digestion, absorption, and adhesion, as well as reconstruct the anatomical structure, contributing to the alleviation of hemorrhagic intestinal adhesion. In summary, we developed a novel dual-functions nhGelMA hydrogel for alleviating hemorrhagic intestinal adhesion via immunomodulation and anti-fibrosis, providing a promising strategy with clinical translational potential. Nevertheless, the current strategy still requires more support from intestinal adhesion models and more data from large animals before it can be applied in clinical settings.

4. Materials and methods

4.1. Preparation of nhGelMA

To prepare GelMA, 10 g gelatin (Aladdin, G108394) was added into 100 mL deionized water, and stirred in a water bath at 50 °C until fully dissolved. Subsequently, the solution was slowly added 6 mL methacrylic anhydride (Aladdin, M102519) was slowly added and the mixture was allowed to react in a 50 °C constant-temperature shaker for 6 hours. After the reaction, the solution was transferred into a dialysis bag with a molecular weight cutoff of 3.5 kDa and dialyzed in deionized water for 2 days. Following dialysis, the solution was centrifuged at 3000 rpm for 10 minutes, as well as the supernatant was collected, frozen at -80 °C, and then freeze-dried for 2 days to obtain GelMA precursor (29). GelMA hydrogel was prepared by mixing the 5% GelMA precursor and 0.2% lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) under 365 nm ultraviolet (UV) light excitation. Similarly, the nhGelMA hydrogel was prepared by mixing 5% GelMA, 0.2% LAP, Houttuynia cordata extract (10 mg/ml), and Nintedanib (20 ug/ml) with UV light excitation.

4.2. ¹H NMR analysis

To confirm the successful preparation of GelMA, nuclear magnetic resonance hydrogen spectroscopy (¹H NMR) was conducted on gelatin and GelMA. 10 mg gelatin and GelMA were dissolved in 0.5 mL deuterated dimethyl sulfoxide (DMSO, Sigma, 151831) containing 0.03% tetramethylsilane (TMS) as an internal standard. Subsequently, 0.4 mL of each solution was transferred into a 5 mm NMR tube, and ¹H NMR measurements were performed using a Bruker 600 MHz NMR spectrometer (Germany). After data collection, the spectra were processed using MestReNova software. Characteristic peaks were identified: GelMA exhibited additional peaks at approximately 5.3-5.8 ppm, corresponding to the vinyl protons from methacryloyl groups, thereby confirming the methacrylation process.

4.3. Mechanical property

The hydrogel samples were prepared with a 1 cm diameter and a 3 mm thickness. Compressive tests were conducted using a universal testing machine equipped with a 500 N loading (INSTRON 5982). Briefly, the samples were placed on the compression platen and compressed at a rate of 1 mm/min until they reached 80% of their original thickness. The compression modulus was obtained from the stress-strain curve, where the modulus is defined as the slope of this linear segment (30).

4.4. CCK-8 assay

To evaluate the cytotoxicity of hydrogels, a CCK-8 assay was conducted using fibroblasts. First, 20 μL of hydrogel was added to the well of a 96-well plate and allowed to solidify under 365 nm UV light excitation. Subsequently, fibroblasts were seeded at a density of 5×10³ cells per well with 100 μL culture medium. The plate was incubated at 37 °C in a incubator for 24 hours. Then, 10 μL CCK-8 reagent (DOJINDO, CK04) was added to each well with 90 μL culture medium, and the incubation continued for another 2 hours under the same conditions. The absorbance at 450 nm was measured using a microplate reader. Relative cell viability was calculated based on the blank group.

4.5. Rheological analyses and viscosity measurements

Rheological tests were conducted using a HAAKE MARS Rotational Rheometer equipped with parallel-plate geometry (P20 TiL, 20 mm diameter) at 25 °C. The rheology experiments involved exposing the samples to light irradiation (365 nm, 20 mW/cm²). A time sweep oscillatory test was conducted under the conditions of 10% strain, 1 Hz frequency, and 0.5 mm gap for 120 s, during which the storage modulus (G’) and loss modulus (G’’) were recorded. All tests were performed in triplicate, and the data were analyzed using the instrument’s software to generate relevant curves and viscoelastic parameters.

4.6. Swelling tests of the hydrogels

Swelling tests of the hydrogels were conducted using a gravimetric method. The initial wet weight of the hydrogel samples was recorded as W0. The hydrogels were subsequently immersed in PBS at 37 °C for 2 h, 4 h, 8 h, and 12 h. After this period, the hydrogels were carefully removed, and their wet weights were measured and recorded as Wt. The swelling ratio at each time point was calculated using the formula: Swelling ratio = (Wt - W0)/W0 × 100%.

4.7. Degradation test of the hydrogels

Degradation tests of the hydrogels were performed by a gravimetric method. The initial dry weight of the lyophilized hydrogel samples was recorded as W0. The hydrogels were then immersed in PBS with 10µg/ml collagenase (Aladdin, C754929) at 37 °C. At designated time intervals 12 h, 24 h, 48 h, and 72h, the hydrogels were carefully removed, lyophilized, and their weights were measured and recorded as Wt. The degradation ratio at each time point was calculated using the formula: Degradation ratio = (W0 - Wt)/W0 × 100%.

4.8. Sustained released tests

Sustained release tests of houttuynia cordata extract from hydrogels were performed by an absorbance method. nhGelMA hydrogels containing 10 mg/ml houttuynia cordata extract were immersed in PBS at 37 °C with supernatants collected at 12 h, 24 h, 48 h, and 72 h. The standard curve was established by measuring the PBS solutions with 0 μg/ml, 1 μg/ml, 10 μg/ml, 100 μg/ml, 1000 μg/ml, 10 mg/ml, and 100 mg/ml houttuynia cordata extract. Then the standard curve plotted with concentration as the x-axis and OD value as the y-axis. The release rate of houttuynia cordata extract in the supernatants calculated based on the standard curve. Similarly. sustained release tests of Nintedanib from nhGelMA hydrogels were performed by a liquid chromatography method. nhGelMA hydrogels loaded with Nintedanib were immersed in PBS at 37 °C with supernatants collected at 12 h, 24 h, 48 h, and 72 h. The standard curve was harvested by measuring the release medium solutions with 0 ug/ml, 1 ug/ml, 10 ug/ml, and 100 ug/ml. Then the standard curve plotted with concentration as the abscissa and peak area as the ordinate. The release rate of Nintedanib in the supernatants calculated based on the standard curve.

4.9. SEM and element analysis

SEM observations and element analysis were performed using a ZEISS GeminiSEM 300 instrument (Germany). The lyophilized samples were sputter-coated with gold to enhance conductivity. SEM images were captured at accelerating voltage of 5 kV. Element distribution was analyzed via energy-dispersive spectroscopy (EDS) Mapping, which facilitated the detection and visualization of the elemental composition across the sample surface (31).

4.10. XRD and FTIR

XRD analysis was performed using a Rigaku SmartLab SE instrument (Japan) with a scanning angle range of 10-80° and a scanning speed of 2°/min. FTIR measurements were conducted using a Nicolet iS20 instrument (Thermo Fisher Scientific, USA) with a wavenumber range of 400–4000 cm-1 to characterize the functional groups of the samples.

4.11. Isolation and culture of fibroblasts

Rabbit skin tissue was harvested and rinsed with PBS containing antibiotics. The tissue was then cut into small pieces using sterile scissors. Subsequently, the pieces were immersed in PBS with 0.2% Dispase II (Aladdin, D743370) and incubated at 37 °C for 8 hours to facilitate the separation of the epidermis from the dermis. A 0.1% collagenase solution (Merck, C0773) was added, and the mixture was incubated at 37 °C for 2 hours to digest the dermal tissue. The cell suspension was filtered through a cell strainer to remove undigested tissue fragments, and the filtrate was centrifuged at 1000 rpm for 5 minutes to isolate the cells, which were subsequently cultured in DMEM supplemented with 10% fetal bovine serum and 1% antibiotics (32).

4.12. Live/dead staining

Cells were seeded onto the hydrogels and cultured for 72 hours. Following the removal of the culture medium, the samples were gently rinsed twice with PBS to remove residual medium. A Live/Dead staining solution (DOJINDO) was applied to cover the hydrogels, and the samples were incubated at 37 °C for 10 minutes. After incubation, the staining solution was aspirated, and the samples were then rinsed with PBS to remove any excess dye. The stained cells were then observed immediately under a fluorescence microscope (Leica), where live cells exhibited green fluorescence and dead cells emitted red fluorescence.

4.13. PCR

Total RNA was extracted from samples using a TRIzol reagent according to the manufacturer’s instructions. cDNA was synthesized from total RNA using a reverse transcription kit based on the kit protocol. PCR amplification was performed in a 20 μL reaction system, which included10 μL of 2× PCR Master Mix, 1 μL of forward primer (10 μM), 1 μL of reverse primer (10 μM), 2 μL of cDNA template, and 6 μL of nuclease-free water. The relative expression level of the target gene was calculated using the 2^(-ΔΔCt) method (33). Primers were designed and synthesized by Sangon Biotech (Shanghai).

4.14. Surgery and ethic

New Zealand white rabbits (2 kg, 2 months) were purchased from Shanghai Jiagan Biotechnology Co., Ltd. The rabbits were anesthetized using isoflurane, after which the abdominal area was depilated and disinfected. A midline abdominal incision was made to open the abdominal cavity, and the appendix was carefully identified and exposed. The appendix was scratched with a scalpel handle to create a bleeding model. In the experimental group, nhGelMA was applied to the injured area for treatment, while the control group received no treatment. After the procedure, the abdominal cavity was closed layer by layer. All animal procedures were approved by the Animal Care and Experimental Committee of Nantong University (S20250818-001).

4.15. Immunofluorescence staining

The rabbits were euthanized after 3 days repair and the intestines were harvested. The samples were fixed in 4% paraformaldehyde for 24 hours, followed by dehydration and sectioning at a thickness of 4-5 μm. The sections were dewaxed to water, subjected to antigen retrieval, and then blocked with 5% BSA at room temperature for 30 minutes. Primary antibodies against FN (Abcam, ab286324), LAMA (Abcam, ab151715), Col1 (Abcam, ab270994), CD3 (Abcam, ab16669), and CD68 (HUABIO, HA601292) were added to the sections, which were then incubated overnight at 4 °C for 12 h. After washing containing phosphate-buffered saline with Tween 20 (PBST), fluorescently labeled secondary antibodies were added, and the sections were incubated in the dark at 37 °C for 1 hour. Finally, the sections were counterstained with DAPI for 5 minutes and observed under a fluorescence microscope. Images were captured for subsequent analysis.

4.17. Statistical analysis

All data are presented as mean ± standard deviation (SD). A t-test was utilized for comparisons between two groups, whereas a one-way analysis of variance (ANOVA) was applied. A p-value less than 0.05 was considered statistically significant.

Acknowledgments

We would like to express our gratitude for the funding provided by the High-level Talent Start-up Fund of Nantong First People’s Hospital. The schematic diagrams presented in this article were created using BioRender software.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. This study was supported by High-level talent start-up fund of Nantong First People’s Hospital (YJRCJJ006 and YJRCJJ0012).

Footnotes

Edited by: Ronghan Liu, Shandong Academy of Medical Sciences (SDAMS), China

Reviewed by: Shuai Tang, Imdea Materials Institute, Spain

Kai Jiang, Fudan University, China

Jinyi Huang, Imdea Materials Institute, Spain

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Ethics statement

All animal procedures were approved by the Animal Care and Experimental Committee of Nantong University. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

PY: Funding acquisition, Writing – original draft, Software, Investigation. SF: Investigation, Writing – original draft, Formal analysis. CT: Investigation, Writing – original draft, Formal analysis. XG: Writing – original draft, Investigation, Formal analysis. SQ: Investigation, Writing – original draft, Formal analysis. GC: Supervision, Conceptualization, Methodology, Validation, Funding acquisition, Writing – review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2026.1777773/full#supplementary-material

DataSheet1.docx (795.3KB, docx)

References

  • 1. Carmichael SP, Shin J, Vaughan JW, Chandra PK, Holcomb JB, Atala AJ. Regenerative medicine therapies for prevention of abdominal adhesions: A scoping review. J Surg Res. (2022) 275:252–64. doi:  10.1016/j.jss.2022.02.005, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Wang M, Lin S, Liu M, Jiao J, Mi H, Sun J, et al. An injectable and rapidly degraded carboxymethyl chitosan/polyethylene glycol hydrogel for postoperative antiadhesion. Chem Eng J. (2023) 463:142283. doi:  10.1016/j.cej.2023.142283, PMID: 41756733 [DOI] [Google Scholar]
  • 3. Teo ZY, Senthilkumar SD, Srinivasan DK. Nanotechnology-based therapies for preventing post-surgical adhesions. Pharmaceutics. (2025) 17:389. doi:  10.3390/pharmaceutics17030389, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Okabayashi K, Ashrafian H, Zacharakis E, Hasegawa H, Kitagawa Y, Athanasiou T, et al. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity. Surg Today. (2014) 44:405–20. doi:  10.1007/s00595-013-0591-8, PMID: [DOI] [PubMed] [Google Scholar]
  • 5. Zhao B, Zhu P, Zhang H, Gao Y, Zha L, Jin L, et al. Nanofiber hydrogel drug delivery system for prevention of postsurgical intestinal adhesion. ACS Biomater Sci Eng. (2024) 10:3164–72. doi:  10.1021/acsbiomaterials.3c01936, PMID: [DOI] [PubMed] [Google Scholar]
  • 6. Tian W, Xu X, Zhao R, Tian T, Li W, Huang M, et al. High visceral fat-to-muscle ratio predicated a recurrent fistula after definitive surgery for a small intestinal fistula with diffuse extensive abdominal adhesions: a cohort study. Int J Surg. (2023) 109:3490–6. doi:  10.1097/JS9.0000000000000647, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Li X, Guo Y, Wang Z, Guo X, Wang J, Zhang J, et al. Platelet-rich fibrin promotes mesothelial cell proliferation and peritoneal repair by up-regulating calretinin to prevent postoperative intestinal adhesion. Int J Med Sci. (2025) 22:1254–68. doi:  10.7150/ijms.105523, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Jin L, Zhao Y, Qian X, Pan L, Chen L, Feng J, et al. LC-MS/MS-based metabolomics and proteomics reveal the intervention of Kangnian decoction on the postoperative intestinal adhesion of rats. Front Pharmacol. (2024) 15:1382760. doi:  10.3389/fphar.2024.1382760, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Al Samaraee A, Bhattacharya V. Facing the unexpected: unusual causes of mechanical small bowel obstruction in adults. Clin J Gastroenterol. (2021) 14:1287–302. doi:  10.1007/s12328-021-01450-2, PMID: [DOI] [PubMed] [Google Scholar]
  • 10. Ghimire P, Maharjan S. Adhesive small bowel obstruction: A review. J Nepal Med Assoc. (2023) 61:390–6. doi:  10.31729/jnma.8134, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Crippa J, Magistro C, Montroni I, Borroni G, Ziccarelli A, Spinelli A, et al. Charting connections: A systematic review of colorectal surgery research networks. Eur J Surg Oncol. (2024) 50:108322. doi:  10.1016/j.ejso.2024.108322, PMID: [DOI] [PubMed] [Google Scholar]
  • 12. Chandel AKS, Shimizu A, Hasegawa K, Ito T. Advancement of biomaterial-based postoperative adhesion barriers. Macromol Biosci. (2021) 21:2000395. doi:  10.1002/mabi.202000395, PMID: [DOI] [PubMed] [Google Scholar]
  • 13. Kang SI, Shin HH, Hyun DH, Yoon G, Park JS, Ryu JH. Double-layer adhesives for preventing anastomotic leakage and reducing post-surgical adhesion. Mater Today Bio. (2023) 23:100806. doi:  10.1016/j.mtbio.2023.100806, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Wang Z, Li S, Qi D, Gao Y, Geng Y, Zou Z, et al. Tissue-adhesive, antibacterial, and antioxidant hydrogel sealant for sealing colorectal anastomotic leakage and preventing postoperative adhesion. Adv Healthc Mater. (2025) 14:2501171. doi:  10.1002/adhm.202501171, PMID: [DOI] [PubMed] [Google Scholar]
  • 15. Han Q, Yu J, Gao Z, Li S, Wang Z, Wu J, et al. Polypyrrole-modified gelatin-based hydrogel: A dressing for intestinal perforation treatment with enhanced wound healing and anti-adhesion properties. Int J Biol Macromol. (2025) 309:142738. doi:  10.1016/j.ijbiomac.2025.142738, PMID: [DOI] [PubMed] [Google Scholar]
  • 16. Su Y, Ju J, Shen C, Li Y, Yang W, Luo X, et al. In situ 3D bioprinted GDMA/PRussian blue nanozyme hydrogel with wet adhesion promotes macrophage phenotype modulation and intestinal defect repair. Mater Today Bio. (2025) 31:101636. doi:  10.1016/j.mtbio.2025.101636, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Wu J, Deng J, Theocharidis G, Sarrafian TL, Griffiths LG, Bronson RT, et al. Adhesive anti-fibrotic interfaces on diverse organs. Nature. (2024) 630:360–7. doi:  10.1038/s41586-024-07426-9, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Joshi A, Nuntapramote T, Brüggemann D. Self-assembled fibrinogen scaffolds support cocultivation of human dermal fibroblasts and haCaT keratinocytes. ACS Omega. (2023) 8:8650–63. doi:  10.1021/acsomega.2c07896, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Zhang R, Zou C, Jiang L, Bai B, Li C, Zhang C, et al. Repair of spinal cord injury using a time-specific four-dimensional multifunctional hydrogel with anti-inflammatory and neuronal differentiated microenvironments. Biomater Sci. (2025) 13:4153–67. doi:  10.1039/D4BM01586J, PMID: [DOI] [PubMed] [Google Scholar]
  • 20. Laldinsangi C. The therapeutic potential of Houttuynia cordata: A current review. Heliyon. (2022) 8:e10386. doi:  10.1016/j.heliyon.2022.e10386, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Pan L, Cheng Y, Yang W, Wu X, Zhu H, Hu M, et al. Nintedanib ameliorates bleomycin-induced pulmonary fibrosis, inflammation, apoptosis, and oxidative stress by modulating PI3K/akt/mTOR pathway in mice. Inflammation. (2023) 46:1531–42. doi:  10.1007/s10753-023-01825-2, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Yan J, Feng G, Yang Y, Zhao X, Ma L, Guo H, et al. Nintedanib ameliorates osteoarthritis in mice by inhibiting synovial inflammation and fibrosis caused by M1 polarization of synovial macrophages via the MAPK/PI3K-AKT pathway. FASEB J. (2023) 37:e23177. doi:  10.1096/fj.202300944RR, PMID: [DOI] [PubMed] [Google Scholar]
  • 23. Nunes R, Broering MF, De Faveri R, Goldoni FC, Mariano LNB, Mafessoli PCM, et al. Effect of the metanolic extract from the leaves of Garcinia humilis Vahl (Clusiaceae) on acute inflammation. Inflammopharmacol. (2021) 29:423–38. doi:  10.1007/s10787-019-00645-x, PMID: [DOI] [PubMed] [Google Scholar]
  • 24. Wang T, Xu W, Zhao X, Bai B, Hua Y, Tang J, et al. Repair of osteochondral defects mediated by double-layer scaffolds with natural osteochondral-biomimetic microenvironment and interface. Mater Today Bio. (2022) 14:100234. doi:  10.1016/j.mtbio.2022.100234, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kurian AG, Singh RK, Patel KD, Lee J-H, Kim H-W. Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics. Bioactive Mater. (2022) 8:267–95. doi:  10.1016/j.bioactmat.2021.06.027, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Wu X, Huo Y, Ci Z, Wang Y, Xu W, Bai B, et al. Biomimetic porous hydrogel scaffolds enabled vascular ingrowth and osteogenic differentiation for vascularized tissue-engineered bone regeneration. Appl Mater Today. (2022) 27:101478. doi:  10.1016/j.apmt.2022.101478, PMID: 41756733 [DOI] [Google Scholar]
  • 27. Loessner D, Meinert C, Kaemmerer E, Martine LC, Yue K, Levett PA, et al. Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms. Nat Protoc. (2016) 11:727–46. doi:  10.1038/nprot.2016.037, PMID: [DOI] [PubMed] [Google Scholar]
  • 28. Asadi N, Sadeghzadeh H, Rahmani Del Bakhshayesh A, Nezami Asl A, Dadashpour M, Karimi Hajishoreh N, et al. Preparation and characterization of propolis reinforced eggshell membrane/GelMA composite hydrogel for biomedical applications. BMC Biotechnol. (2023) 23:21. doi:  10.1186/s12896-023-00788-4, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Hao J, Bai B, Ci Z, Tang J, Hu G, Dai C, et al. Large-sized bone defect repair by combining a decalcified bone matrix framework and bone regeneration units based on photo-crosslinkable osteogenic microgels. Bioactive Mater. (2022) 14:97–109. doi:  10.1016/j.bioactmat.2021.12.013, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Bai B, Hao J, Hou M, Wang T, Wu X, Liu Y, et al. Repair of large-scale rib defects based on steel-reinforced concrete-designed biomimetic 3D-printed scaffolds with bone-mineralized microenvironments. ACS Appl Mater Interfaces. (2022) 14:42388–401. doi:  10.1021/acsami.2c08422, PMID: [DOI] [PubMed] [Google Scholar]
  • 31. Bai B, Liu Y, Huang J, Wang S, Chen H, Huo Y, et al. Tolerant and rapid endochondral bone regeneration using framework-enhanced 3D biomineralized matrix hydrogels. Adv Sci. (2024) 11:2305580. doi:  10.1002/advs.202305580, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Song X, Bai B, Li K, Wei X, Wang Y, Jia Z, et al. Epithelialized chimeric repairing patch supports in situ healing of tracheal fistula. Sci Adv. (2025) 11(7):eadt1320. doi:  10.1126/sciadv.adt1320, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Hou M, Bai B, Tian B, Ci Z, Liu Y, Zhou G, et al. Cartilage regeneration characteristics of human and goat auricular chondrocytes. Front Bioeng Biotechnol. (2021) 9:766363. doi:  10.3389/fbioe.2021.766363, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

DataSheet1.docx (795.3KB, docx)

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES